Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Boyett

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|August 11, 2006
A sequential procedure for monitoring clinical trials against historical controlsXiaoping Xiong, Ming Tan, James Boyett
Biometrics|November 7, 2003
Sequential conditional probability ratio tests for normalized test statistic on information timeXiaoping Xiong, Ming Tan, James Boyett
Neuro-Oncology|February 18, 2015
Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 childrenCynthia Wetmore, James Boyett, Shaoyu Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2014
18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortiumKatherine Zukotynski, Frederic Fahey, Mehmet Kocak, et al.
Aging Cell|February 25, 2026
Silencing of the Metabolic Gene HKDC1 Is Associated With Aging and Neurodegeneration in Mice and HumansZeenat Farooq, Vladimir Ilievski, James Boyett, et al.
Pediatric Blood & Cancer|May 21, 2016
High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702)Kellie J Nazemi, Violet Shen, Jonathan L Finlay, et al.
Neurotoxicology|April 22, 2026
Arsenic Attenuates Responsiveness to Inflammatory Stimuli in the SIM-A9 Microglial Cell LineLuyu Wang, Lidan Zhao, James Boyett, et al.
Clinical Pharmacology and Therapeutics|June 18, 2003
Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemiaThierry Dervieux, Michael L Hancock, Ching-Hon Pui, et al.
Cancer Immunology, Immunotherapy : CII|August 22, 2017
Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11)Sridharan Gururangan, Elizabeth Reap, Robert Schmittling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001)Susan M Blaney, James Boyett, Henry Friedman, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|August 11, 2006
A sequential procedure for monitoring clinical trials against historical controlsXiaoping Xiong, Ming Tan, James Boyett
Biometrics|November 7, 2003
Sequential conditional probability ratio tests for normalized test statistic on information timeXiaoping Xiong, Ming Tan, James Boyett
Neuro-Oncology|February 18, 2015
Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 childrenCynthia Wetmore, James Boyett, Shaoyu Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 30, 2014
18F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortiumKatherine Zukotynski, Frederic Fahey, Mehmet Kocak, et al.
Aging Cell|February 25, 2026
Silencing of the Metabolic Gene HKDC1 Is Associated With Aging and Neurodegeneration in Mice and HumansZeenat Farooq, Vladimir Ilievski, James Boyett, et al.
Pediatric Blood & Cancer|May 21, 2016
High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702)Kellie J Nazemi, Violet Shen, Jonathan L Finlay, et al.
Neurotoxicology|April 22, 2026
Arsenic Attenuates Responsiveness to Inflammatory Stimuli in the SIM-A9 Microglial Cell LineLuyu Wang, Lidan Zhao, James Boyett, et al.
Clinical Pharmacology and Therapeutics|June 18, 2003
Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemiaThierry Dervieux, Michael L Hancock, Ching-Hon Pui, et al.
Cancer Immunology, Immunotherapy : CII|August 22, 2017
Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11)Sridharan Gururangan, Elizabeth Reap, Robert Schmittling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001)Susan M Blaney, James Boyett, Henry Friedman, et al.
Pageof 2